KRYS - Krystal Biotech - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KRYS is currently covered by 9 analysts with an average price target of $340.42. This is a potential upside of $15.85 (4.88%) from yesterday's end of day stock price of $324.57.

Krystal Biotech's activity chart (see below) currently has 186 price targets and 167 ratings on display. The stock rating distribution of KRYS is 92.59% BUY and 7.41% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 97.2% with an average time for these price targets to be met of 223.3 days.

Highest price target for KRYS is $441, Lowest price target is $217, average price target is $340.42.

Most recent stock forecast was given by ANDREA TAN from GOLDMAN SACHS on 24-Sep-2026. First documented stock forecast 18-Oct-2017.

Best performing analysts who are covering KRYS - Krystal Biotech:

Roger Song Andrea Tan Geulah Livshits Yigal Nochomovitz Joshua Schimmer

Currently out of the existing stock ratings of KRYS, 25 are a BUY (92.59%), 2 are a HOLD (7.41%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 20-Nov-2023

$441

$118.72 (36.84%)

$327

14 days ago
(24-Sep-2026)

3/4 (75%)

$96.04 (27.84%)

123

Buy Since 19-Jan-2022

$400

$77.72 (24.12%)

$396

17 days ago
(21-Sep-2026)

8/10 (80%)

$66.15 (19.81%)

183

Buy Since 12-Jan-2026

$386

$63.72 (19.77%)

$378

2 months 4 days ago
(04-Aug-2026)

10/11 (90.91%)

$61.23 (18.85%)

178

Buy Since 29-Nov-2021

$403

$30.75 (8.26%)

$306

3 months 20 days ago
(18-Jun-2026)

9/10 (90%)

$54.94 (15.78%)

254

Buy Since 24-Sep-2018

$361

$-11.25 (-3.02%)

$310

3 months 22 days ago
(16-Jun-2026)

46/46 (100%)

$37.63 (11.64%)

207

Show more analysts

Please expand the browser size to see the chart

What is KRYS (Krystal Biotech) average time for price targets to be met?

On average it took 223 days for the stock forecasts to be reached, with an average price target met ratio of 97.2%.

Which analyst most recently updated their price target on KRYS (Krystal Biotech)?

Andrea Tan

Which analyst has the most public recommendations on KRYS (Krystal Biotech)?

Andrea Tan works at GOLDMAN SACHS and has 4 price targets and 3 ratings on KRYS

Which analyst is the currently most bullish on KRYS (Krystal Biotech)?

Andrea Tan with the highest potential upside of $118.72

Which analyst is the currently most reserved on KRYS (Krystal Biotech)?

Wangzhi Li with the lowest potential downside of -$272.28
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?